Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic

Teresa Rubio1, Vicente Felipo1, Sonia Tarazona2

  • 1Laboratory of Neurobiology, Centro Investigación Príncipe Felipe, Valencia, Spain.

Scientific Reports
|January 22, 2021
PubMed

Insights

Minimal hepatic encephalopathy (MHE) in liver cirrhosis patients involves immune system shifts. This study reveals altered immune pathways and molecular changes linked to MHE, offering new insights into cognitive impairment.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Minimal hepatic encephalopathy (MHE) impacts liver cirrhosis patients' quality of life and survival.
  • Peripheral inflammation shifts are implicated in MHE development, but underlying mechanisms are unclear.

Purpose of the Study:

  • Investigate broad molecular changes in MHE.
  • Identify altered genes, pathways, serum metabolites, and cytokines in MHE patients.
  • Explore MHE-regulated immune responses linked to serum molecule changes.

Main Methods:

  • Multi-omic approach: transcriptomic, metabolomic, and cytokine profiling of blood samples.
  • Analysis of cirrhotic patients with and without MHE.
  • Integration of extracellular and intracellular data.

Main Results:

  • Transcriptomics indicate Th1/Th2/Th17 lymphocyte alterations in MHE.
  • Six serum molecule clusters suggest functional modules in MHE induction.
  • Specific cytokines (CCL20, CX3CL1, CXCL13, IL-15, IL-22, IL-6) linked to chemotaxis alterations.
  • Long-chain unsaturated phospholipids associated with fatty acid transport and prostaglandin production.

Conclusions:

  • Altered immune pathways contribute to MHE's mild cognitive impairment phenotype.
  • Multi-omic integration provides novel insights into MHE pathogenesis.
  • Findings open new avenues for understanding and potentially treating MHE.